[HTML][HTML] Therapeutic efficacy of gefitinib and erlotinib in patients with advanced lung adenosquamous carcinoma
Z Song, B Lin, L Shao, Y Zhang - Journal of the Chinese Medical …, 2013 - Elsevier
Background Adenosquamous carcinoma (ASC) of the lung is a rare subtype of nonsmall-cell
lung cancer (NSCLC). To date, the efficacious targeted therapy for advanced ASC remains …
lung cancer (NSCLC). To date, the efficacious targeted therapy for advanced ASC remains …
Therapeutic efficacy of gefitinib and erlotinib in patients with advanced lung adenosquamous carcinoma
Z Song, B Lin, L Shao, Y Zhang - Journal of the Chinese Medical …, 2013 - journals.lww.com
Background: Adenosquamous carcinoma (ASC) of the lung is a rare subtype of nonsmall-
cell lung cancer (NSCLC). To date, the efficacious targeted therapy for advanced ASC …
cell lung cancer (NSCLC). To date, the efficacious targeted therapy for advanced ASC …
Therapeutic efficacy of gefitinib and erlotinib in patients with advanced lung adenosquamous carcinoma
Z Song, B Lin, L Shao, Y Zhang - Journal of the Chinese Medical …, 2013 - infona.pl
Adenosquamous carcinoma (ASC) of the lung is a rare subtype of nonsmall-cell lung cancer
(NSCLC). To date, the efficacious targeted therapy for advanced ASC remains unclear and …
(NSCLC). To date, the efficacious targeted therapy for advanced ASC remains unclear and …
[PDF][PDF] Therapeutic efficacy of gefitinib and erlotinib in patients with advanced lung adenosquamous carcinoma
Z Song, B Lin, L Shao, Y Zhang - Journal of the Chinese Medical …, 2013 - core.ac.uk
Background: Adenosquamous carcinoma (ASC) of the lung is a rare subtype of nonsmall-
cell lung cancer (NSCLC). To date, the efficacious targeted therapy for advanced ASC …
cell lung cancer (NSCLC). To date, the efficacious targeted therapy for advanced ASC …
Therapeutic efficacy of gefitinib and erlotinib in patients with advanced lung adenosquamous carcinoma.
Z Song, B Lin, L Shao, Y Zhang - Journal of the Chinese Medical …, 2013 - europepmc.org
Background Adenosquamous carcinoma (ASC) of the lung is a rare subtype of nonsmall-cell
lung cancer (NSCLC). To date, the efficacious targeted therapy for advanced ASC remains …
lung cancer (NSCLC). To date, the efficacious targeted therapy for advanced ASC remains …
Therapeutic efficacy of gefitinib and erlotinib in patients with advanced lung adenosquamous carcinoma
Z Song, B Lin, L Shao, Y Zhang - Journal of the Chinese …, 2013 - pubmed.ncbi.nlm.nih.gov
Background Adenosquamous carcinoma (ASC) of the lung is a rare subtype of nonsmall-cell
lung cancer (NSCLC). To date, the efficacious targeted therapy for advanced ASC remains …
lung cancer (NSCLC). To date, the efficacious targeted therapy for advanced ASC remains …